LifeMD closed at $2.29 on Nov 5, down 6.53%, 59.3% below its 52-week closing high. Volume of 600.2K shares was 0.87× its 20-day average (close to normal).
Split-adjusted performance: -17.9% over one month, -49.0% over six months, -57.7% over one year.
In the quarter ended Jun 30, 2026, revenue was $47.28M, down 3.5% from a year earlier, with a net margin of -16.6%.
Short interest was 7.4M shares at the Oct 15 settlement, down 2.1% from the prior report (18.4% of float, 11.0 days to cover).